Connect with us

Technology

Nicolas S. Piuzzi, MD, Presented Kappa Delta Young Investigator Award for Research on Employing Data Analytics to Improve Patient Outcomes

Published

on

ROSEMONT, Ill., Feb. 7, 2025 /PRNewswire/ — Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award winner for research showing how leveraging advanced analytics with personalized outcome prediction tools can optimize the outcomes and satisfaction of total hip and knee arthroplasty (THA, TKA) for patients. Utilizing patient-reported outcomes measures (PROMs) can help clinicians identify risk factors and predict outcomes more accurately, allowing for tailored interventions at the patient level. The award recognizes outstanding clinical research related to musculoskeletal disease or injury by investigators under 40 years old or no more than seven years beyond training.

To read more about the award, please click here.

Each year, approximately 790,000 TKAs and 544,000 THAs are performed in the U.S., numbers that are expected to grow due to an aging population.[i] PROMs have become an increasingly important measure for total joint arthroplasty (TJA) as health care systems shift toward a value-based model, especially in light of the fact that the Centers for Medicare & Medicaid Services (CMS) implemented guidelines for 2025 that will require hospitals to submit pre- and postoperative PROMs data for THA and TKA to receive full CMS reimbursement. PROMs provide insights into patients’ perspectives on their pain, function and quality of life before and after surgery.

Even with successful surgical outcomes following THA and TKA, 10 to 20% of patients report persistent pain, functional limitations or unmet expectations one year following surgery.[ii] Dr. Piuzzi and his colleagues from Cleveland Clinic Adult Reconstruction Research (CCARR) from the Department of Orthopaedic Surgery, Cleveland Clinic, theorized that incorporating data analytics and PROMs could help practitioners identify patients who may be at a higher risk for poor outcomes, potentially closing the gap between surgical outcomes and patient satisfaction.

“Musculoskeletal conditions, such as osteoarthritis, represent the leading cause of disability and impose a growing economic and health burden on our society,[iii]” said Dr. Piuzzi, associate staff and director of research, Cleveland Clinic Adult Reconstruction Research Department of Orthopaedic Surgery, and Cleveland Clinic Musculoskeletal Research Center co-director. “Despite affecting over one-third of the U.S. population and accounting for hundreds of billions in annual health-care costs, these conditions remain underfunded in research, highlighting an urgent need for action to advance innovative treatments and improve patient outcomes. Specifically, hip and knee arthroplasties can be very costly for our healthcare system and patients. While these procedures have been performed successfully for many years, we asked ourselves how we could incorporate the same level of data that other industries use to give patients a detailed assessment of what they can expect with joint replacement and to determine which risk factors need to be included in the modeling.”

Creating a Comprehensive Data Collection System
In 2015, the Cleveland Clinic developed the Orthopaedic Minimal Data Set Episode of Care database as a comprehensive PROMs data collection platform specifically for TJA.[iv] Patient demographics, general health PROMs, joint-specific PROMs, and disease severity and treatment details are captured from patients and surgeons at specific points in time following surgery. Integrating PROMs collection into the routine clinical workflow achieved a high baseline completion rate (>97%) for TJA procedures. Passive and active follow-up methods, including automated email reminders, text messages and electronic health record messages, are used to ensure patients are reached. If patients do not respond, telephone calls and personalized mailed letters are sent. A study published by the research team shows passive measures captured one-year PROMs for 38% of the THA cohort and 40% of the TKA cohort.[v] A significant portion of patients ― 40% for THA and 41% for TKA ― required more active follow-up to complete their postoperative PROMs. The study showed the need for a multimodal approach to patient follow-up to collect PROMs data.

Preoperative PROMs Phenotypes Lead to Individualized Approach
Using preoperative PROMs phenotypes that incorporate pain, function and mental health provides for a more accurate representation of each patient’s unique needs and risk factors, allowing surgeons to individualize the approach and better predict outcomes after TJA.

In a study of 4,034 primary THA patients, Dr. Piuzzi and the research team defined eight distinct phenotypes based on combinations of above or below median scores for Hip Disability and Osteoarthritis Outcome Score (HOOS) pain, HOOS-Physical Function Shortform (HOOS-PS), and Veterans RAND 12 Item Health Survey-Mental Health Summary Measure (VR-12 MCS), which is a self-administered health survey that captures physical and mental health aspects.[vi] The study found that phenotypes characterized by lower-than-median VR-12 MCS scores were significantly associated with increased dissatisfaction at one year, regardless of pain or function scores. Patients with the phenotype representing below-median scores across all three PROMs had the highest odds of dissatisfaction compared to the reference phenotype.

By identifying patients with high-risk phenotypes, clinicians can develop targeted interventions to optimize patients’ preoperative condition and manage expectations.

“The variation between the different phenotypes is a 9 to 10% risk of failure to a 25% risk of failure related to patient satisfaction and perception of improvement,” said Dr. Piuzzi. “This gives practitioners a very powerful tool to counsel patients and address some of the risk factors for each patient. If you have a patient in the high-risk group who is having mental health issues or poor function, clinicians need to set expectations and address some of the issues to mitigate risk factors. It is very applicable as it is readily available to everyone, but we need to ensure the data is collected, analyzed and implemented.”

Developing a Predictive Model
With value-based health care becoming more important, there is a need for a data-driven, standardized approach to guide the shared decision-making process in TJA. Integrating PROMs and relevant patient characteristics into a comprehensive predictive model allows for the development of a personalized outcome prediction tool that can estimate the likelihood of improved pain, function and quality of life after surgery for individuals.

The Cleveland Clinic research team built a tool for TKA that incorporated separate models for predicting length of stay; 90-day readmission; and one-year improvements in Knee Injury and Osteoarthritis Outcome Score (function and quality of life sub-scores). These models include a range of patient factors ― demographics, comorbidities, baseline PROMs and laboratory values ― and allow the predictive tool to consider modifiable risk factors. The personalized outcome prediction tool demonstrated high accuracy in predicting outcomes for new patients. This demonstrates the potential for using data-driven models to provide patients and surgeons with individualized estimates of expected outcomes based on preoperative characteristics and PROMs.

About the Kappa Delta Awards
The Kappa Delta Awards, the first of which was established by the Kappa Delta Sorority and awarded in 1950, are presented by the AAOS to persons who have performed research in orthopaedic surgery that is of high significance and impact. The sorority would later add two more awards, valued at $20,000 each. Two awards are named for the sorority national past presidents who were instrumental in the creation of the awards: Elizabeth Winston Lanier and Ann Doner Vaughn. The third is known as the Young Investigator Award.

For more information, please visit aaos.org/kappadelta. Learn more about the Kappa Delta Foundation, here.

About the AAOS
With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world’s largest medical association of musculoskeletal specialists. The AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level to best treat patients in their daily practices. The AAOS is the source for information on bone and joint conditions, treatments and related musculoskeletal health care issues; and it leads the health care discussion on advancing quality.

Follow the AAOS on Facebook, X, LinkedIn and Instagram.

________________________________________
i American College of Rheumatology. Joint Replacement Surgery. Published February 2024. Accessed Dec. 18, 2024. https://rheumatology.org/patients/joint-replacement-surgery
ii Orr MN, Klika AK, Emara AK, et al. 2022. Dissatisfaction After Total Hip Arthroplasty Associated with Preoperative Patient-Reported Outcome Phenotypes. J. Arthroplasty 37(7S):S498–S509.
iii McConaghy K, Klika AK, Apte SS, Erdemir A, Derwin K, Piuzzi NS. A Call to Action for Musculoskeletal Research Funding: The Growing Economic and Disease Burden of Musculoskeletal Conditions in the United States Is Not Reflected in Musculoskeletal Research Funding. J Bone Joint Surg Am. 2023 Mar 15;105(6):492-498.
iv OME Cleveland Clinic Orthopaedics. Implementing a Scientifically Valid, Cost-Effective, and Scalable Data Collection System at Point of Care: The Cleveland Clinic OME Cohort. J Bone Joint Surg Am. 2019 Mar 6;101(5):458-464.
v Rullán PJ, Pasqualini I, Zhang C, et al. 2024. How to Raise the Bar in the Capture of Patient-Reported Outcome Measures in Total Joint Arthroplasty: Results from Active and Passive Follow-up Measures. J. Bone Joint Surg. Am. 106(10):879–890.
 vi Emara AK, Orr MN, Klika AK, et al. 2022. When is Surgery Performed? Trends, Demographic Associations, and Phenotypical Characterization of Baseline Patient-Reported Outcomes Before Total Hip Arthroplasty. J. Arthroplasty 37(6):1083–1091.e3.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nicolas-s-piuzzi-md-presented-kappa-delta-young-investigator-award-for-research-on-employing-data-analytics-to-improve-patient-outcomes-302370799.html

SOURCE American Academy of Orthopaedic Surgeons

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

RSPO Launches New Guidance to Leverage Sustainable Palm Oil Certification for IFRS® Sustainability Disclosure Standards

Published

on

By

KUALA LUMPUR, Malaysia, July 23, 2026 /PRNewswire/ — The Roundtable on Sustainable Palm Oil (RSPO) has released a guidance document, “Leveraging RSPO Principles and Criteria for IFRS® Sustainability Disclosure Standards”. This new resource supports certified sustainable palm oil producers to align their sustainability practices with the IFRS S1 and IFRS S2 disclosure standards that serve as the global framework for reporting sustainability-related financial information.

As more than 30 jurisdictions, representing around 60% of global GDP, move towards adoption of the IFRS Sustainability Disclosure Standards (IFRS SDS), companies are increasingly required to disclose how sustainability-related risks and opportunities affect their financial position and prospects.1

This resource provides a practical pathway for palm oil producers to respond to these requirements by leveraging their existing compliance with the RSPO Principles and Criteria (P&C), without duplicating efforts or creating parallel systems.

Informing investor-relevant disclosures: A four-step approach

Certification and the IFRS SDS serve different purposes. This guidance, developed with support from PwC Malaysia, provides a practical bridge between operational sustainability practices and financial disclosure expectations by helping members translate certification-related topics, metrics, and evidence to inform investor-relevant disclosures.

It sets out a four-step approach to IFRS SDS-aligned reporting, guiding RSPO Members on applicability, reporting boundaries, identification of sustainability-related risks and opportunities, and links to financial performance. It also includes seven practical examples, illustrating how the RSPO P&C requirements and implementation evidence can inform disclosures across key sustainability topics, from ethical conduct and legal compliance to environmental protection and worker health and safety.

Beyond growers, the guidance document also supports financial institutions by helping banks, insurers, and investors understand how palm oil sustainability issues, such as labour disputes and traceability gaps, can translate into financial risks, impacts, and opportunities, enabling clearer risk profiling and more informed financing decisions.

Joseph D’ Cruz, RSPO Chief Executive Officer, said: “As sustainability reporting becomes an integral pillar of financial performance, this guidance bridges certification and disclosure, providing RSPO members with a practical framework to demonstrate sustainability performance in ways that resonate with global capital markets. In line with the growing importance of sustainability disclosures in financing and investment decision-making processes, this guidance illustrates how RSPO Principles and Criteria practices can complement an organisation’s strategy and risk assessment processes.”

Andrew Chan, Partner, Sustainability Leader at PwC Malaysia, said: “This guidance responds to the broader shift towards measuring sustainability through a financial lens, with the adoption of the IFRS Sustainability Disclosure Standards (IFRS S1 and IFRS S2). For RSPO growers, this creates an opportunity to demonstrate how sustainability practices contribute to business resilience as well as value creation — building investor confidence for the long term.”

Importantly, the guidance also reflects RSPO’s longer term interest in progressively strengthening linkages with sustainability disclosure frameworks. As disclosure expectations continue to evolve, RSPO intends to further explore how certification-related data metrics and assurance processes can support broader and more integrated sustainability disclosures in the future.

The Guidance Document can be downloaded here.

For more information, visit www.rspo.org 

About RSPO:
The Roundtable on Sustainable Palm Oil (RSPO) is a global partnership to make palm oil sustainable. Formed in 2004, the RSPO is a multi-stakeholder non-profit organisation that unites members from across the palm oil value chain, including oil palm producers, palm oil processors and traders, consumer goods manufacturers, retailers, banks and investors, environmental or nature conservation non-governmental organisations (NGOs), and social or developmental NGOs.

As a partnership for progress and positive impact, the RSPO facilitates global change to make the production and consumption of palm oil sustainable. To inspire change, we communicate the environmental and social benefits. To make progress, we catalyse collaboration. To provide assurance, we set the standards of certification.

The RSPO is registered as an international association in Zurich, Switzerland, with main offices in Malaysia and Indonesia, and offices in China, Colombia, Netherlands, United Kingdom and the United States. 

About PwC:
At PwC, we help clients build trust and reinvent so they can turn complexity into competitive advantage. We’re a tech-forward, people-empowered network with more than 364,000 people in 136 countries and 137 territories. Across audit and assurance, tax and legal, deals and consulting, we help clients build, accelerate, and sustain momentum. Find out more at www.pwc.com

1

IFRS Foundation, ISSB Podcast February 2025

 

View original content:https://www.prnewswire.com/apac/news-releases/rspo-launches-new-guidance-to-leverage-sustainable-palm-oil-certification-for-ifrs-sustainability-disclosure-standards-302833097.html

SOURCE Roundtable On Sustainable Palm Oil

Continue Reading

Technology

Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform

Published

on

By

WALTHAM, Mass., 23 July 2026 /PRNewswire/ — Nordic Capital today announced that it has entered into a definitive agreement to sell ArisGlobal, a leading provider of software to the life sciences industry, to Dassault Systèmes (Euronext Paris: FR0014003TT8) (Paris: DSY.PA). The transaction represents a full exit for Nordic Capital and marks the successful culmination of a partnership that has transformed ArisGlobal into a scaled, cloud-native and AI-enabled platform serving more than 200 life sciences companies, CROs and government health authorities worldwide.

Founded in 1989 and headquartered in Waltham, Massachusetts, ArisGlobal develops and delivers regulatory, safety, and quality software to a global client base that includes many of the world’s largest pharmaceutical and biotech organisations, as well as regulatory authorities. Its flagship LifeSphere® platform is a fully integrated, cloud-native suite that enables life sciences organisations to manage complex regulatory submissions, pharmacovigilance workflows and clinical data on a single platform, improving compliance, speed and operational efficiency. The platform also embeds advanced AI-enabled automation across core pharmacovigilance workflows, reducing manual processing and accelerating safety case management.

“Nordic Capital invested in ArisGlobal because the business had strong fundamentals, a loyal blue-chip client base and significant potential to modernise its technology and scale its commercial reach. Working closely with Aman and his team, Nordic Capital has supported the company’s transformation into a leading cloud-native platform for the life sciences industry with differentiated AI-enabled capabilities and a strengthened market position. Nordic Capital is proud of what has been achieved together with management and looks forward to seeing the company continue to grow under Dassault Systèmes ownership,” said Daniel Berglund, Partner and Head of Healthcare, Nordic Capital Advisors.

Nordic Capital first invested in ArisGlobal in 2019, partnering with the founding family and management team to pursue an ambitious development strategy. In 2021, Nordic Capital made a further investment in the company, reflecting its conviction in ArisGlobal’s growth potential and the progress achieved since the original partnership began. Throughout the ownership period, Nordic Capital worked closely with management to accelerate the SaaS transition, professionalise the go-to-market organisation, broaden the product offering and strengthen the leadership team.

The migration to a modern, cloud-native architecture created the foundation for ArisGlobal to become an early leader in the application of AI to drug safety. A key milestone was the development and launch of NavaX, ArisGlobal’s generative AI solution for safety case processing, which automates and accelerates core pharmacovigilance workflows and has been adopted by a number of the world’s leading pharmaceutical companies. NavaX has further differentiated ArisGlobal’s offering and marked an important step in the Company’s evolution into a broader, AI-enabled safety and regulatory software platform.

“The life sciences industry is at an inflection point as regulatory complexity is increasing, data volumes are growing and our clients need software that can keep pace. The partnership with Nordic Capital gave us the resources and the runway to build exactly that. NavaX and our expanded platform are the result of that ambition, and I am confident we are well placed for what comes next,” said Aman Wasan, CEO, ArisGlobal.

Alongside its technology transformation, ArisGlobal strengthened its management team and commercial organisation, while two strategic acquisitions broadened the Company’s platform capabilities. Today, ArisGlobal serves more than 200 enterprise customers, including half of the world’s top 50 biopharma companies, processes more than 12 million safety cases annually and is expected to generate approximately USD 175 million in revenue in 2026. As rising regulatory complexity and increasing volumes of adverse event reporting continue to drive demand for advanced life sciences software, ArisGlobal is well positioned for future growth through solutions that automate compliance workflows, reduce manual processing and enable organisations to manage regulatory risk more effectively.

The transaction brings together ArisGlobal’s leadership in AI-enabled safety and regulatory software with Dassault Systèmes’ capabilities across research, clinical development and manufacturing. Nordic Capital believes the combination represents a highly compelling strategic fit, pairing complementary capabilities to create a broader, end-to-end offering across the life sciences value chain. ArisGlobal will also benefit from Dassault Systèmes’ global scale, customer reach and investment capacity, providing a strong platform for its next phase of innovation and growth.

The transaction is subject to customary regulatory approvals and is expected to close in the second half of 2026.

Evercore and Jefferies LLC acted as financial advisors to ArisGlobal and Kirkland & Ellis acted as legal advisor to ArisGlobal.

Media contacts:

Nordic Capital
Katarina Janerud
Communications Manager, Nordic Capital Advisors
+46 8 440 50 50
katarina.janerud@nordiccapital.com

ArisGlobal
Morgan Scott
Vice President, Marketing & Communications and Chief of Staff
mscott@arisglobal.com

About ArisGlobal

ArisGlobal is a leading provider of software to the life sciences industry. Its LifeSphere® platform delivers integrated regulatory, safety, and quality solutions to more than 200 life sciences companies, CROs and government health authorities worldwide. Founded in 1989 and headquartered in Waltham, Massachusetts, ArisGlobal combines deep domain expertise with advanced technology to help clients improve compliance, accelerate development cycles and manage regulatory complexity at global scale. For more information, visit www.arisglobal.com.

About Nordic Capital

Nordic Capital is a leading international private equity investor and subsector specialist dedicated to building stronger, more resilient businesses through transformative, long-term growth in partnership with management teams. With over 35 years of experience, Nordic Capital currently manages approximately EUR 39 billion in assets, investing in middle-market companies across Northern Europe and North America. Rooted in its Nordic heritage and values, it combines global reach with local presence through dedicated sector investment advisory teams, bringing deep expertise across its core sectors: Healthcare, Technology & Payments, Financial Services, and Services & Industrial Tech. Through active ownership, strong operational capabilities, a global network of experts and technology-enabled transformation, Nordic Capital helps companies scale, innovate and become sustainable leaders. For more information, visit www.nordiccapital.com or connect on LinkedIn.

“Nordic Capital” refers to, depending on the context, any, or all, Nordic Capital branded entities, vehicles, structures, and associated entities. The general partners and/or delegated portfolio managers of Nordic Capital’s entities and vehicles are advised by several non-discretionary sub-advisory entities, any or all of which are referred to as “Nordic Capital Advisors”.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/nordic-capital/r/nordic-capital-announces-agreement-to-sell-arisglobal-to-dassault-systemes–following-its-transforma,c4376982

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/nordic-capital-announces-agreement-to-sell-arisglobal-to-dassault-systemes-following-its-transformation-into-a-scaled-and-ai-enabled-life-sciences-platform-302833100.html

Continue Reading

Technology

Cognizant and Gulf Edge Announce Strategic Partnership to Accelerate Enterprise AI Adoption in Southeast Asia

Published

on

By

Partnership combines Cognizant’s global AI engineering capabilities with Gulf Edge’s sovereign digital infrastructure to capture the region’s growing demand for secure, scalable AI solutions.

BANGKOK, July 23, 2026 /PRNewswire/ — Cognizant (Nasdaq: CTSH), a leading AI builder and global technology services provider, and Gulf Edge Company Limited, the digital infrastructure arm of Thai energy and infrastructure conglomerate Gulf Development Public Company Limited (GULF) or Gulf Group, today announced a landmark strategic partnership. The alliance is designed to accelerate enterprise AI adoption and establish a resilient, AI-native digital economy in Thailand and the broader region.

As artificial intelligence (AI) rapidly reshapes industries, economies, and societies worldwide, the partnership aims to establish the foundational ecosystem needed to enable Thailand’s next phase of digital transformation. By combining trusted sovereign digital infrastructure with world-class AI engineering and enterprise transformation capabilities, Gulf Edge and Cognizant will help organizations deploy AI securely, responsibly, and at scale.

The collaboration brings together Gulf Edge’s leadership in digital infrastructure, energy, cloud, and strategic relationships across Thailand’s most important industries with Cognizant’s global expertise in AI, digital engineering, cloud modernization, data, and intelligent operations. Together, the two companies will deliver end-to-end AI capabilities spanning infrastructure, AI platforms, enterprise solutions, systems integration, and managed services.

The partnership will initially focus on accelerating AI adoption across key sectors including banking and financial services, energy and utilities, healthcare, telecommunications, manufacturing, and the public sector. Through industry-specific AI solutions, organizations will be able to improve operational efficiency, enhance customer experience, strengthen decision-making, automate complex business processes, and unlock new opportunities for innovation and growth.

Beyond enterprise transformation, Gulf Edge and Cognizant share a broader ambition of strengthening Thailand’s position as a regional AI hub. The partnership is expected to attract global technology expertise, stimulate investment in advanced digital capabilities, and create high-value employment opportunities across AI engineering, data science, cloud infrastructure, cybersecurity, and digital transformation. The two companies also plan to collaborate with universities, research institutions, technology partners, and public-sector organizations to develop AI talent, promote responsible AI adoption, and foster a sustainable innovation ecosystem for the country.

Mr. Sarath Ratanavadi, Chief Executive Officer, Gulf Development Public Company Limited, said, “Our partnership with Cognizant marks an important milestone in our vision of helping Thailand become an AI-native economy. By combining Gulf Edge’s strengths in digital infrastructure, energy, cloud, and deep understanding of the Thai market with Cognizant’s global expertise in enterprise AI, digital engineering, and transformation services, we are creating a comprehensive platform that enables organizations to adopt AI with confidence and generate measurable business outcomes. Together, we will develop secure, resilient, and future-ready sovereign digital infrastructure while delivering industry-specific AI solutions tailored to the needs of Thai enterprises and public institutions. We believe AI has the potential to transform every sector, creating new opportunities for productivity, innovation, and sustainable economic growth.”

Mr. Ganesh Ayyar, President of Asia Pacific & Japan (APJ), Cognizant, said, “As Thailand works toward its ambition of becoming an AI-native economy, we see this partnership as a meaningful way to help contribute to that vision, not just through the projects we deliver, but by building lasting AI and technology capability inside the country. With Gulf Edge’s market reach and Cognizant’s AI Builder strategy and global delivery capability, we are positioned to deliver transformative outcomes for Thai enterprises across every major sector.”

About Gulf Edge
Gulf Edge Company Limited is the digital infrastructure arm of Gulf Development Public Company Limited, Thailand’s leading energy and infrastructure conglomerate. Gulf Edge is building a robust digital ecosystem, spanning data centers, cloud services, satellite technology, and AI infrastructure, to accelerate Thailand’s digital transformation and position the country as a regional hub for the AI economy.

About Cognizant
Cognizant (NASDAQ: CTSH) is an AI Builder and technology services provider, building the bridge between AI investment and enterprise value by building full-stack AI solutions for clients. Its deep industry, process, and engineering expertise enables it to build an organization’s unique context into technology systems that amplify human potential, realize tangible returns, and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cognizant-and-gulf-edge-announce-strategic-partnership-to-accelerate-enterprise-ai-adoption-in-southeast-asia-302833116.html

SOURCE Gulf Development Public Company Limited (GULF)

Continue Reading

Trending